Search for: "Cost v. Cost" Results 6721 - 6740 of 48,975
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 May 2021, 6:39 pm by Nate Nead
These funds offered high-yield debt capital to companies in shambles that were regarded as too risky for loans by other conventional or direct lenders, often costing borrowers two to three times more than conventional loans and establishing a place of last resort for businesses being pushed towards bankruptcy [6]. [read post]
26 May 2021, 5:00 pm by BKK
Fourth Circuit Court of Appeals recently in Beckley Oncology Assocs. v. [read post]
26 May 2021, 6:30 am by ernst
Andrew Kent, Fordham University School of Law, has posted Lessons for Bivens and Qualified Immunity Debates from Nineteenth-Century Damages Litigation against Federal Officers, which appears in Notre Dame Law Review  96 (2021): 1755-1788:This Essay was written for a symposium marking the fiftieth anniversary of the Supreme Court’s decision in Bivens v. [read post]
25 May 2021, 11:18 am by Robert Percival
ShareJust four weeks after hearing oral argument, the Supreme Court on Monday issued a refreshingly clear, unanimous decision in Guam v. [read post]
24 May 2021, 10:03 am by Lisa Peets, Marty Hansen and Vicky Ling
Notably, it would impose significant administrative costs on high-risk AI systems of around 10 percent of the underlying value, based on compliance, oversight, and verification costs. [read post]
24 May 2021, 9:00 am
Less than a month after hearing oral arguments, the United States Supreme Court issued its unanimous decision in Guam v. [read post]
23 May 2021, 3:24 pm by Giles Peaker
RRO made, in view of Vadamalayan v Stewart and Others (2020) UKUT 183 (LC) on the full rent starting point, for £4163.50 – after a £150 deduction for utility costs. [read post]
23 May 2021, 10:09 am by INFORRM
MailOnline’s position that an expectation of privacy was extinguished by the fact of publication elsewhere was unsustainable, particularly in the light of the recent decision in Sicri v Associated Newspapers Ltd. [read post]
22 May 2021, 2:07 am by Kluwer Patent blogger
Although second medical use protection has had limited importance in the treatment of COVID-19, it has put in the spotlight the overall need for quick reactions to new diseases, which is one of the many factors justifying such protection, according to Jochen Bühling, partner of the German law firm of Krieger Mes & Graf v. der Groeben and editor of ‘Patent Protection for Second Medical Uses’. [read post]